A randomised, placebo-controlled phase 3 study of plozasiran in patients with familial chylomicronemia syndrome
2 September 2024 (11:36 - 11:48)
Organised by: 
Slides
About the speaker
University of Western Australia, Perth (Australia)
4 More presentations in this session
Doctor Y. Kang (Boston, US)
Doctor G. Chi (Boston, US)
Access the full session
The Event
ESC Congress 2024
2 September 2024
11:36 CET
You may be interested in
Congress Session
Congress Session
Congress Session
